Fluorescein sodium–guided resection of cervical peripheral nerve sheath tumors in 3 dogs
Journal of the American Veterinary Medical Association · 13.11.2026 · 1-9
DOI: 10.2460/javma.26.08.0620 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Veterinary Medical Association, erschienen am 13.11.2026. Verfasst von Narae Jeong und 2 weiteren Autor:innen. Beteiligte Einrichtung: 1Department of Veterinary Surgery, Ilsan Animal Medical Center, Goyang-si, Republic of Korea. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
Objective
To describe the intraoperative findings and outcomes of fluorescein sodium-guided resection of cervical peripheral nerve sheath tumors (PNSTs) in dogs, including in the re-operative setting. Animals 3 client-owned dogs with cervical PNST. Two dogs underwent a second resection of progressive malignant PNST (MPNST) after subtotal resection and stereotactic radiation therapy performed elsewhere. One dog underwent primary resection of a previously untreated PNST identified as a schwannoma. Clinical Presentation Affected dogs were between 10 and 11 years of age (weighing between 4.2 and 5.4 kg) and presented with cervical pain, hyperesthesia, or tetraparesis. Preoperative MRI revealed contrast-enhancing intradural extramedullary masses with extraforaminal extensions.
Results
Fluorescein sodium (20 mg/kg) was administered IV after surgical exposure. Tumor tissue exhibited yellow discoloration under standard illumination in all dogs and bright fluorescence under 395-nm UV illumination in 2 dogs and, in the 2 re-operative cases, was visually distinct from the surrounding postoperative and radiation-induced fibrosis, which was grossly assessed as nondiseased and did not take up fluorescein. This contrast assisted dissection, and gross total resection was achieved in all dogs; nonfluorescent tissue was not biopsied. Histopathology confirmed MPNST in 2 dogs and schwannoma in 1 dog. Fluorescein-related adverse events were not observed. Both MPNST cases developed remote or metastatic disease within 4 months (1 euthanized); the schwannoma case was recurrence-free at 3 months. Clinical Relevance Fluorescein sodium–guided resection of canine cervical PNSTs is feasible with widely available equipment and may aid intraoperative identification of tumor tissue in both primary and re-operative settings, suggesting a lower equipment barrier than commonly assumed. Because nonfluorescent tissue was not sampled, fluorescein should be an adjunct to, not a substitute for, surgical judgment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- 1Department of Veterinary Surgery, Ilsan Animal Medical Center, Goyang-si, Republic of Korea.
- 2Laboratory of Veterinary Clinical Neurology, Graduate School of Nippon Veterinary and Life Science University, Tokyo, Japan.
- 3Department of Veterinary Radiology, Ilsan Animal Medical Center, Goyang-si, Republic of Korea.
ORCID-Profile: Narae Jeong, Daisuke Hasegawa, Joohyun Jung
Zitieren
APA
Jeong, N., Hasegawa, D., & Jung, J. (2026). Fluorescein sodium–guided resection of cervical peripheral nerve sheath tumors in 3 dogs. Journal of the American Veterinary Medical Association, 1-9. https://doi.org/10.2460/javma.26.08.0620
Vancouver
Jeong N, Hasegawa D, Jung J. Fluorescein sodium–guided resection of cervical peripheral nerve sheath tumors in 3 dogs. Journal of the American Veterinary Medical Association. 2026:1-9. doi:10.2460/javma.26.08.0620
BibTeX
@article{Jeong2026,
author = {Jeong, Narae and Hasegawa, Daisuke and Jung, Joohyun},
title = {Fluorescein sodium–guided resection of cervical peripheral nerve sheath tumors in 3 dogs},
journal = {Journal of the American Veterinary Medical Association},
year = {2026},
pages = {1--9},
doi = {10.2460/javma.26.08.0620}
}
EUVIMED